# Vaccine Maintenance Treatment for Non-Small Cell Lung Cancer

> **NCT00420732** · PHASE2 · TERMINATED · sponsor: **NewLink Genetics Corporation** · enrollment: 6 (actual)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **BIOLOGICAL:** HyperAcute-Lung Cancer Vaccine

## Key facts

- **NCT ID:** NCT00420732
- **Lead sponsor:** NewLink Genetics Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-01
- **Primary completion:** 2012-11
- **Final completion:** 2014-12
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Enrollment goals unable to be reached.
- **Last updated:** 2020-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00420732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00420732, "Vaccine Maintenance Treatment for Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00420732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*